James Benenati, Robert Lookstein, and Rachel Rosovsky discuss the STORM-PE trial, the first-of-its-kind RCT for acute intermediate-high risk pulmonary embolism (PE).
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.